These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7933648)

  • 1. [Effect of ursodeoxycholate on gene expressions of cholecystokinin and secretin in rat intestine].
    Funakoshi A; Miyasaka K; Kitani K
    Nihon Shokakibyo Gakkai Zasshi; 1994 Sep; 91(9):1469. PubMed ID: 7933648
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a new cholecystokinin antagonist (FK 480) on gene expression of cholecystokinin and secretin in rat intestine.
    Funakoshi A; Miyasaka K
    J Gastroenterol; 1994 Jun; 29(3):385-7. PubMed ID: 8061811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of gene expressions of cholecystokinin and secretin in luminal feedback regulation in conscious rats.
    Miyasaka K; Funakoshi A
    Pancreas; 1995 Mar; 10(2):200-3. PubMed ID: 7716145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in gene expression of pancreatitis-associated protein and pancreatic secretory trypsin inhibitors in experimental pancreatitis produced by pancreatic duct occlusion in rats: comparison with gene expression of cholecystokinin and secretin.
    Funakoshi A; Miyasaka K; Jimi A; Nakamura E; Teraoka H
    Pancreas; 1995 Aug; 11(2):147-53. PubMed ID: 7479671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a cholecystokinin (CCK) antagonist (CR 1505) on gene expressions of CCK and secretin in rat intestine.
    Funakoshi A; Miyasaka K; Kawanami T; Matsumoto M; Takata Y; Kono A
    Pancreas; 1995 Mar; 10(2):118-22. PubMed ID: 7716134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cholecystokinin release and transcription in a rat without gene expression of cholecystokinin-A receptor.
    Miyasaka K; Masuda M; Funakoshi A
    Digestion; 1997; 58(2):104-10. PubMed ID: 9144298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the cholecystokinin precursor gene in rat tissues.
    Funakoshi A; Tanaka A; Kawanami T; Tateishi K; Miyasaka K; Kono A
    J Gastroenterol; 1994 Apr; 29(2):125-8. PubMed ID: 8012503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of trypsin inhibitors on intestinal gene expression of secretin and on pancreatic bicarbonate secretion in CCK-A-receptor-deficient rats.
    Kawanami T; Suzuki S; Yoshida Y; Kanai S; Takata Y; Shimazoe T; Watanabe S; Funakoshi A; Miyasaka K
    Jpn J Pharmacol; 1999 Dec; 81(4):339-45. PubMed ID: 10669038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of ursodeoxycholate on pancreatic exocrine secretion in vitro and in vivo study].
    Shinozaki H; Miyasaka K; Funakoshi A; Kitani K
    Nihon Shokakibyo Gakkai Zasshi; 1992 Jan; 89(1):68-74. PubMed ID: 1373209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ursodeoxycholic acid treatment on the expression and function of multidrug resistance-associated protein 2 in rat intestine.
    Yumoto R; Hamada S; Okada K; Kato Y; Ikehata M; Nagai J; Takano M
    J Pharm Sci; 2009 Aug; 98(8):2822-31. PubMed ID: 19067394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localizations of secretin, cholecystokinin, and somatostatin in the rat small intestine after acute cisplatin treatment.
    Miyamoto Y; Miyamoto M
    Exp Mol Pathol; 2004 Dec; 77(3):238-45. PubMed ID: 15507242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intraduodenal administration of a low dose of cholecystokinin (CCK) antagonist (CR-1505) on plasma CCK concentration, intestinal CCK content, and levels of CCK mRNA.
    Sazaki N; Miyasaka K; Matsumoto M; Funakoshi A
    J Gastroenterol; 1995 Oct; 30(5):599-606. PubMed ID: 8574331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cholecystokinin gene expression in rat intestine.
    Liddle RA
    Ann N Y Acad Sci; 1994 Mar; 713():22-31. PubMed ID: 7910441
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in messenger RNA of pancreatic enzymes and intestinal cholecystokinin after a 7-day bile-pancreatic juice diversion from the proximal small intestine in rats.
    Hara H; Ochi Y; Kasai T
    Biosci Biotechnol Biochem; 1997 Jun; 61(6):1002-6. PubMed ID: 9214762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The secretin gene: evolutionary history, alternative splicing, and developmental regulation.
    Kopin AS; Wheeler MB; Nishitani J; McBride EW; Chang TM; Chey WY; Leiter AB
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5335-9. PubMed ID: 1711228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific expression of the rat secretin precursor gene.
    Ohta M; Funakoshi S; Kawasaki T; Itoh N
    Biochem Biophys Res Commun; 1992 Mar; 183(2):390-5. PubMed ID: 1550548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of octapeptide-cholecystokinin, secretin, and glucagon on intestinal mucosal growth in parenterally nourished rats.
    Weser E; Bell D; Tawil T
    Dig Dis Sci; 1981 May; 26(5):409-16. PubMed ID: 6265170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretin: structure of the precursor and tissue distribution of the mRNA.
    Kopin AS; Wheeler MB; Leiter AB
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2299-303. PubMed ID: 2315322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cholecystokinin and secretin on intestinal structure and function.
    Fine H; Levine GM; Shiau YF
    Am J Physiol; 1983 Sep; 245(3):G358-63. PubMed ID: 6311031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ursodeoxycholic acid on the pharmacokinetics of midazolam and CYP3A in the liver and intestine of rats.
    Kurosawa S; Uchida S; Ito Y; Yamada S
    Xenobiotica; 2009 Feb; 39(2):162-70. PubMed ID: 19255942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.